在创制新药的研究中寻找和发现具有生物活性的先导化合物是至关重要的环节之一,而对大量化合物进行活性筛选则是发现先导化合物的主要手段和途径。近年来,我们应用以受体为靶点的药物筛选模型筛选新药技术取得了一定的成果。所谓受体配体结合技术,就是利用从器官中分离出细胞膜 Finding and discovering biologically active lead compounds is one of the most important steps in the research of new drug discovery. However, screening large numbers of compounds for activity screening is the primary means and route to discover lead compounds. In recent years, we have achieved some results by screening new drug technologies using drug screening models targeting receptors. The so-called receptor ligand binding technology, is the use of isolated from the organs of the cell membrane